Sign in

CIK 0001082554

  • Large accelerated filer

UNITED THERAPEUTICS Corp

Sign in to watch
Ticker
UTHR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
521984749
Phone
+1 301-608-9292
Business address
1000 SPRING ST, SILVER SPRING, MD, 20910
  1. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $522.87 ($4,967,292)
  2. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $530.11 ($5,036,073)
  3. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $531.38 ($5,048,137)
  4. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $525.36 ($4,990,873)
  5. 4 Planned sale EVP & GENERAL COUNSEL sold 8,300 shares at an average $517.05 ($4,291,512)
  6. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $518.74 ($4,927,985)
  7. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $517.09 ($4,912,310)
  8. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $516.06 ($4,902,569)
  9. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $518.96 ($4,930,098)
  10. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $524.90 ($4,986,594)
  11. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $522.37 ($4,962,488)
  12. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $526.73 ($5,003,976)
  13. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $530.42 ($5,038,971)
  14. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $531.74 ($5,051,519)
  15. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $528.58 ($5,021,520)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 164 · 3,269 filings